Home > Result Summaries: Compounds > rosiglitazone/metformin > Result Summary for 113492_1

Result Summary for 113492_1

Result Summary

Protocol ID:	113492_1
Clinical Study ID:	WWE113492
Official Title:	Balanced cohort study of thiazolidinediones (TZDs) and other antidiabetic therapies and coronary heart disease events
Phase:	N/A
Study Indications or Diseases:
Generic Name:	rosiglitazone/metformin
Trade/Product Name:	Avandamet,Avandamet XR
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger, JD. The Risk of Coronary Heart Disease in Type 2 Diabetic Patients Exposed to Thiazolidinediones Compared to Metformin and Sulfonylurea Therapy. Pharmacoepidemiology and Drug Safety 2007;16(5): 504-512